Document is current
Any future updates will be listed below
-
Authors
Liu, Yuxia https://orcid.org/0000-0003-1736-9253
Gao, Duyang
He, Yuanyuan
Ma, Jing
Chong, Suet Yen
Qi, Xinyi
Ting, Hui Jun
Luo, Zichao https://orcid.org/0000-0001-9236-9160
Yi, Zhigao https://orcid.org/0000-0003-0853-2055
Tang, Jingyu
Chang, Chao https://orcid.org/0000-0002-4081-1583
Wang, Jiongwei https://orcid.org/0000-0001-7986-6082
Sheng, Zonghai https://orcid.org/0000-0003-0289-029X
Zheng, Hairong https://orcid.org/0000-0002-8558-5102
Liu, Xiaogang https://orcid.org/0000-0003-2517-5790
-
Funding
Funding for this research was provided by:
National Research Foundation Singapore (NRF-NRFI052019-0003)
Government of Guangdong Province (2023A1515010747)
- License Information
-
More Information
Article History
Received: 31 January 2024
Accepted: 4 November 2024
First Online: 13 November 2024
Competing interests
: X.L., Y.L., and Z.L. are co-inventors on a Singapore patent application related to the use of lanmodulin-derived contrast agents for magnetic resonance imaging (application no. 10202400550P), filed by the National University of Singapore. The other authors declare no competing interests.
